EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Medical University of Vienna · Amsterdam UMC Location University of Amsterdam · +39 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,761
total citations
- FWCI
- 203.22
- Percentile
- 100%
- References
- 158
Citations per year
Authors
33- JSJosef S SmolenCorresponding
Medical University of Vienna
- RLRobert Landewé
Amsterdam UMC Location University of Amsterdam, Atrium Medisch Centrum Parkstad, University of Amsterdam
- FCFerdinand C. Breedveld
Leiden University Medical Center
- MHMaya H Buch
University of Leeds, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit
- GBGerd Burmester
Cal Poly Humboldt, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin
Topics & keywords
Topics
Keywords
- Medicine
- Abatacept
- Adalimumab
- Certolizumab pegol
- Tocilizumab
- Golimumab
- Infliximab
- Etanercept
UN Sustainable Development Goals
- Peace, Justice and strong institutions
No related works found for this paper.